Trident Texofab Limited (BOM:540726)

Trident Texofab Revenue

Trident Texofab had revenue of 261.43M INR in the quarter ending June 30, 2026, a decrease of -6.89%. This brings the company's revenue in the last twelve months to 1.16B, down -6.70% year-over-year. In the fiscal year ending March 31, 2026, Trident Texofab had annual revenue of 1.18B, down -3.30%.

• Revenue (ttm): 1.16B
• Revenue Growth: -6.70%
• P/S Ratio: 0.29
• Revenue / Employee: 18.43M
• Employees: 63
• Market Cap: 342.20M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.18B	-40.34M	-3.30%
Mar 31, 2025	1.22B	225.73M	22.69%
Mar 31, 2024	994.84M	31.27M	3.25%
Mar 31, 2023	963.56M	120.63M	14.31%
Mar 31, 2022	842.93M	343.67M	68.83%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error